Artificial intelligence is increasingly moving into the health care arena and helping to streamline medical processes — including the creation of new drugs. Insilico Medicine, an AI-driven biotech company based in Hong Kong and in New York City, recently announced that its new AI-designed drug for COVID-19 has entered Phase […]
clinical
NIH Launches Clinical Trials for Long COVID Treatments
Through the RECOVER Initiative, NIH has launched multiple clinical trials to study interventions for the most common symptoms of Long COVID. Through the RECOVER Initiative, NIH has launched multiple clinical trials to study interventions for the most common symptoms of Long COVID. What you need to know Most […]
First long COVID treatment clinical trials from NIH getting underway
Two new clinical trials to test potential treatments for long COVID are now set to launch, the National Institutes of Health said Monday, opening enrollment for the first of an array of federally-funded studies aimed at evaluating treatments for long-term symptoms still faced by many COVID-19 survivors. They will begin […]
World’s first AI-designed COVID drug starts clinical trials
For the first time ever, a COVID-19 drug entirely designed by generative AI has been approved for human use and will soon begin clinical trials in China, the Canadian-founded company announced Thursday. The drug, named ISM3312, was discovered in a matter of months by multinational biotechnology company Insilico Medicine. Believed […]
A Clinical Psychologist Shares How to Exercise With Depression
Do you wonder what the best way is to count sets and reps? Why you shouldn’t skip leg day? We have answers. This is #Gains, Explained, a space for you to ask any and every question about fitness. The Men’s Health team (and other experts) are here for you. To […]
Ionis announces AstraZeneca’s initiation of the Phase 2b clinical study of its antisense medicine targeting PCSK9 to lower LDL-cholesterol | News
CARLSBAD, Calif., Nov. 30, 2020 /PRNewswire/ — Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) today announced that the biopharmaceutical company AstraZeneca has initiated a Phase 2b clinical trial of ION449 (AZD8233), an investigational antisense medicine designed to reduce blood cholesterol levels in patients with dyslipidemia by targeting proprotein convertase subtilisin/kexin type 9 (PCSK9), an important regulator […]
Study in Nature Medicine Shows Superior Outcomes for Patients in The Leukemia & Lymphoma Society’s Paradigm-Shifting Beat AML Clinical Trial
RYE BROOK, N.Y., Oct. 26, 2020 /PRNewswire/ — Patients participating in The Leukemia & Lymphoma Society’s (LLS) groundbreaking precision medicine Beat AML Master Clinical Trial had superior outcomes compared to acute myeloid leukemia (AML) patients who opted for standard chemotherapy treatment, according to findings published today in the prestigious Nature […]
Study in Nature Medicine shows superior patient outcomes in LLS’s Beat AML clinical trial
Rye Brook, NY (Monday, October 26, 2020) – Patients participating in The Leukemia & Lymphoma Society’s (LLS) groundbreaking precision medicine Beat AML Master Clinical Trial had superior outcomes compared to acute myeloid leukemia (AML) patients who opted for standard chemotherapy treatment, according to findings published today in the prestigious Nature […]